Literature DB >> 5931305

Carcinoma of the breast--the significance of supraclavicular lymph node metastases.

S M Jackson.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5931305     DOI： 10.1016/s0009-9260(66)80066-1

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


× No keyword cloud information.
  7 in total

Review 1.  The significance of a supraclavicular node metastasis in patients with breast cancer. A literature review.

Authors:  J M Debois
Journal:  Strahlenther Onkol       Date:  1997-01       Impact factor: 3.621

Review 2.  Patterns of recurrence in Western and Japanese women with breast cancer.

Authors:  M A Chaudary
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

Review 3.  A meta-analysis of the prognosis in patients with breast cancer with ipsilateral supraclavicular lymph node metastasis versus patients with stage IIIb/c or IV breast cancer.

Authors:  Xu-Hong Liu; Lei Zhang; Bo Chen
Journal:  Chronic Dis Transl Med       Date:  2016-02-19

4.  Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases.

Authors:  Hong Pan; Hui Wang; Mengjia Qian; Xinrui Mao; Guojian Shi; Ge Ma; Muxin Yu; Hui Xie; Lijun Ling; Qiang Ding; Kai Zhang; Shui Wang; Wenbin Zhou
Journal:  JAMA Netw Open       Date:  2021-03-01

5.  The value of radiotherapy in breast cancer patients with isolated ipsilateral supraclavicular lymph node metastasis without distant metastases at diagnosis: a retrospective analysis of Chinese patients.

Authors:  San-Gang Wu; Jia-Yuan Sun; Juan Zhou; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Zhen-Yu He
Journal:  Onco Targets Ther       Date:  2014-02-15       Impact factor: 4.147

6.  Survey of UK practice for management of breast cancer metastases to the neck.

Authors:  B Bisase; C Kerawala
Journal:  Ann R Coll Surg Engl       Date:  2012-10       Impact factor: 1.891

7.  An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment.

Authors:  Tae-Kyung Yoo; Jung Min Chang; Hee-Chul Shin; Wonshik Han; Dong-Young Noh; Hyeong-Gon Moon
Journal:  BMC Cancer       Date:  2017-05-31       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.